• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌与肿瘤微环境的研究趋势:2014年至2023年发表研究的文献计量分析

Research trends in lung cancer and the tumor microenvironment: a bibliometric analysis of studies published from 2014 to 2023.

作者信息

Huang Zhilan, Xie Tingyi, Xie Wei, Chen Zhuni, Wen Zhiyuan, Yang Lin

机构信息

The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.

Department of Respiratory Medicine, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China.

出版信息

Front Oncol. 2024 Jul 31;14:1428018. doi: 10.3389/fonc.2024.1428018. eCollection 2024.

DOI:10.3389/fonc.2024.1428018
PMID:39144829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11322073/
Abstract

BACKGROUND

Lung cancer (LC) is one of the most common malignant tumors in the world and the leading cause of cancer-related deaths, which seriously threatens human life and health as well as brings a heavy burden to the society. In recent years, the tumor microenvironment (TME) has become an emerging research field and hotspot affecting tumor pathogenesis and therapeutic approaches. However, to date, there has been no bibliometric analysis of lung cancer and the tumor microenvironment from 2014 to 2023.This study aims to comprehensively summarize the current situation and development trends in the field from a bibliometric perspective.

METHODS

The publications about lung cancer and the tumor microenvironment from 2014 to 2023 were extracted from the Web of Science Core Collection (WoSCC). The Microsoft Excel, Origin, R-bibliometrix, CiteSpace, and VOSviewer software are comprehensively used to scientifically analyze the data.

RESULTS

Totally, 763 publications were identified in this study. A rapid increase in the number of publications was observed after 2018. More than 400 organizations published these publications in 36 countries or regions. China and the United States have significant influence in this field. Zhou, CC and Frontiers in Immunology are the most productive authors and journals respectively. Besides, the most frequently cited references were those on lung cancer pathogenesis, clinical trials, and treatment modalities. It suggests that novel lung cancer treatment models mainly based on the TME components, such as cancer-associated fibroblasts (CAFs) may lead to future research trends.

CONCLUSIONS

The field of lung cancer and the tumor microenvironment research is still in the beginning stages. Gene expression, molecular pathways, therapeutic modalities, and novel detection technologies in this field have been widely studied by researchers. This is the first bibliometric study to comprehensively summarize the research trend and development regarding lung cancer and tumor microenvironment over the last decade. The result of our research provides the updated perspective for scholars to understand the key information and cutting-edge hotspots in this field, as well as to identify future research directions.

摘要

背景

肺癌是全球最常见的恶性肿瘤之一,也是癌症相关死亡的主要原因,严重威胁人类生命健康,给社会带来沉重负担。近年来,肿瘤微环境(TME)已成为影响肿瘤发病机制和治疗方法的新兴研究领域和热点。然而,迄今为止,尚未有对2014年至2023年肺癌与肿瘤微环境的文献计量分析。本研究旨在从文献计量学角度全面总结该领域的现状和发展趋势。

方法

从科学引文索引核心合集(WoSCC)中提取2014年至2023年关于肺癌与肿瘤微环境的出版物。综合使用Microsoft Excel、Origin、R-bibliometrix、CiteSpace和VOSviewer软件对数据进行科学分析。

结果

本研究共识别出763篇出版物。2018年后出版物数量迅速增加。36个国家或地区的400多个组织发表了这些出版物。中国和美国在该领域具有重大影响力。周,CC和《免疫学前沿》分别是发文量最多的作者和期刊。此外,被引用频率最高的参考文献是关于肺癌发病机制、临床试验和治疗方式的文献。这表明主要基于肿瘤微环境成分(如癌症相关成纤维细胞(CAFs))的新型肺癌治疗模型可能引领未来研究趋势。

结论

肺癌与肿瘤微环境研究领域仍处于起步阶段。该领域的基因表达、分子途径、治疗方式和新型检测技术已受到研究人员的广泛研究。这是首次全面总结过去十年肺癌与肿瘤微环境研究趋势和发展的文献计量学研究。我们的研究结果为学者们了解该领域的关键信息和前沿热点以及确定未来研究方向提供了最新视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ab/11322073/d150d68a964c/fonc-14-1428018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ab/11322073/a79feee79eaf/fonc-14-1428018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ab/11322073/adfe2faab120/fonc-14-1428018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ab/11322073/46c72a25bd6e/fonc-14-1428018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ab/11322073/cf3832c10079/fonc-14-1428018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ab/11322073/d150d68a964c/fonc-14-1428018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ab/11322073/a79feee79eaf/fonc-14-1428018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ab/11322073/adfe2faab120/fonc-14-1428018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ab/11322073/46c72a25bd6e/fonc-14-1428018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ab/11322073/cf3832c10079/fonc-14-1428018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ab/11322073/d150d68a964c/fonc-14-1428018-g005.jpg

相似文献

1
Research trends in lung cancer and the tumor microenvironment: a bibliometric analysis of studies published from 2014 to 2023.肺癌与肿瘤微环境的研究趋势:2014年至2023年发表研究的文献计量分析
Front Oncol. 2024 Jul 31;14:1428018. doi: 10.3389/fonc.2024.1428018. eCollection 2024.
2
A bibliometric and visual analysis of cancer-associated fibroblasts.癌症相关成纤维细胞的文献计量学和可视化分析。
Front Immunol. 2023 Dec 19;14:1323115. doi: 10.3389/fimmu.2023.1323115. eCollection 2023.
3
Liver cancer from the perspective of single-cell sequencing: a review combined with bibliometric analysis.从单细胞测序角度看肝癌:综述与文献计量分析相结合。
J Cancer Res Clin Oncol. 2024 Jun 24;150(6):316. doi: 10.1007/s00432-024-05855-7.
4
Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study.溶瘤病毒治疗中枢神经系统肿瘤的研究热点和趋势:文献计量学研究。
Front Immunol. 2022 Sep 6;13:975695. doi: 10.3389/fimmu.2022.975695. eCollection 2022.
5
Immunotherapy improves disease prognosis by affecting the tumor microenvironment: A bibliometric study.免疫疗法通过影响肿瘤微环境来改善疾病预后:文献计量学研究。
Front Immunol. 2022 Oct 6;13:967076. doi: 10.3389/fimmu.2022.967076. eCollection 2022.
6
A bibliometric and visualized in oral microbiota and cancer research from 2013 to 2022.2013年至2022年口腔微生物群与癌症研究的文献计量学及可视化分析
Discov Oncol. 2024 Feb 1;15(1):24. doi: 10.1007/s12672-024-00878-5.
7
Bibliometric analysis of bone metastases from lung cancer research from 2004 to 2023.2004年至2023年肺癌骨转移研究的文献计量分析。
Front Oncol. 2024 Aug 6;14:1439209. doi: 10.3389/fonc.2024.1439209. eCollection 2024.
8
Worldwide productivity and research trend of publications concerning tumor immune microenvironment (TIME): a bibliometric study.全球肿瘤免疫微环境(TIME)相关出版物的生产力和研究趋势:一项文献计量学研究。
Eur J Med Res. 2023 Jul 10;28(1):229. doi: 10.1186/s40001-023-01195-3.
9
Global research trends and focus on the link between neutrophil extracellular traps and tumor: a bibliometric and visualization analysis from 2006 to 2024.全球关于中性粒细胞胞外陷阱与肿瘤之间关联的研究趋势和重点:2006 年至 2024 年的文献计量学和可视化分析。
Front Immunol. 2024 Sep 24;15:1452104. doi: 10.3389/fimmu.2024.1452104. eCollection 2024.
10
Research trends and hotspots in the immune microenvironment related to osteosarcoma and tumor cell aging: a bibliometric and visualization study.骨肿瘤免疫微环境与肿瘤细胞衰老相关的研究趋势和热点:基于文献计量学和可视化的研究
Front Endocrinol (Lausanne). 2023 Nov 8;14:1289319. doi: 10.3389/fendo.2023.1289319. eCollection 2023.

引用本文的文献

1
The landscape of research on B cell and immunotherapy in solid tumors over the past 20 years.过去20年实体瘤中B细胞与免疫治疗的研究概况。
Discov Oncol. 2025 Aug 22;16(1):1597. doi: 10.1007/s12672-025-03458-3.
2
Emerging trends of the tumor microenvironment in peritoneal malignancies (2010-2024): a visualization analysis.腹膜恶性肿瘤中肿瘤微环境的新趋势(2010 - 2024年):可视化分析
Front Oncol. 2025 Jun 4;15:1515476. doi: 10.3389/fonc.2025.1515476. eCollection 2025.
3
Diagnostic, prognostic, and immunological roles of FUT8 in lung adenocarcinoma and lung squamous cell carcinoma.

本文引用的文献

1
mutation testing, treatment and survival in stage I-III non-small cell lung cancer: CancerLinQ Discovery database retrospective analysis.I 期-III 期非小细胞肺癌的突变检测、治疗和生存:CancerLinQ Discovery 数据库回顾性分析。
Future Oncol. 2024;20(28):2083-2096. doi: 10.1080/14796694.2024.2347826. Epub 2024 Jun 25.
2
Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer.奥希替尼联合抗血管生成疗法为奥希替尼耐药的非小细胞肺癌提供了一个有前景的选择。
BMC Med. 2024 Apr 24;22(1):174. doi: 10.1186/s12916-024-03389-w.
3
Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges.
FUT8在肺腺癌和肺鳞癌中的诊断、预后及免疫作用
PLoS One. 2025 May 15;20(5):e0321756. doi: 10.1371/journal.pone.0321756. eCollection 2025.
4
Research hotspots and frontiers in the tumor microenvironment of colorectal cancer: a bibliometric study from 2014 to 2024.结直肠癌肿瘤微环境的研究热点与前沿:一项2014年至2024年的文献计量学研究
Front Oncol. 2025 Feb 5;15:1525280. doi: 10.3389/fonc.2025.1525280. eCollection 2025.
5
Research Status and Direction of Chronic Obstructive Pulmonary Disease Complicated with Coronary Heart Disease: A Bibliometric Analysis from 2005 to 2024.慢性阻塞性肺疾病合并冠心病的研究现状与方向:2005年至2024年的文献计量分析
Int J Chron Obstruct Pulmon Dis. 2025 Jan 7;20:23-41. doi: 10.2147/COPD.S495326. eCollection 2025.
非小细胞肺癌中靶向治疗和免疫治疗的耐药机制:克服挑战的有前景策略
Front Immunol. 2024 Apr 9;15:1366260. doi: 10.3389/fimmu.2024.1366260. eCollection 2024.
4
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma.单细胞 RNA-seq 和批量 RNA-seq 的综合分析揭示了免疫抑制亚型,并建立了一个新的特征,用于确定肺腺癌的预后。
Cell Oncol (Dordr). 2024 Oct;47(5):1697-1713. doi: 10.1007/s13402-024-00948-4. Epub 2024 Apr 15.
5
IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.肿瘤相关巨噬细胞中的 IL6-STAT3-C/EBPβ-IL6 正反馈环促进肺腺癌的 EMT 和转移。
J Exp Clin Cancer Res. 2024 Feb 29;43(1):63. doi: 10.1186/s13046-024-02989-x.
6
Macrophage-Derived Exosomes as Advanced Therapeutics for Inflammation: Current Progress and Future Perspectives.巨噬细胞衍生的外泌体作为炎症的先进治疗方法:当前进展和未来展望。
Int J Nanomedicine. 2024 Feb 19;19:1597-1627. doi: 10.2147/IJN.S449388. eCollection 2024.
7
Targeting focal adhesion kinase boosts immune response in KRAS/LKB1 co-mutated lung adenocarcinoma via remodeling the tumor microenvironment.靶向粘着斑激酶通过重塑肿瘤微环境增强KRAS/LKB1共突变肺腺癌的免疫反应。
Exp Hematol Oncol. 2024 Jan 30;13(1):11. doi: 10.1186/s40164-023-00471-6.
8
Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer.癌症相关成纤维细胞表型与非小细胞肺癌患者预后相关。
Cancer Cell. 2024 Mar 11;42(3):396-412.e5. doi: 10.1016/j.ccell.2023.12.021. Epub 2024 Jan 18.
9
Musashi-2 in cancer-associated fibroblasts promotes non-small cell lung cancer metastasis through paracrine IL-6-driven epithelial-mesenchymal transition.癌症相关成纤维细胞中的Musashi-2通过旁分泌白细胞介素-6驱动的上皮-间质转化促进非小细胞肺癌转移。
Cell Biosci. 2023 Nov 8;13(1):205. doi: 10.1186/s13578-023-01158-5.
10
The incidence and mortality of lung cancer in China: a trend analysis and comparison with G20 based on the Global Burden of Disease Study 2019.中国肺癌的发病率和死亡率:基于《2019年全球疾病负担研究》的趋势分析及与二十国集团的比较
Front Oncol. 2023 Aug 9;13:1177482. doi: 10.3389/fonc.2023.1177482. eCollection 2023.